H.C. Wainwright lowered the firm’s price target on Applied DNA Sciences to $2 from $4 and keeps a Buy rating on the shares following the fiscal Q4 report. The analyst says testing revenue continued to sequentially decline in the quarter.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APDN:
